NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31

NuCana plc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026

$0.98−0.01 (-1.30%)

Close on Oct 19, 2026

NuCana plc cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30
Depreciation & Amortization	0.36	0.32	0.31	0.31	0.29	0.29	0.28	0.28	0.25	0.23	0.22	0.21	0.14	0.13	0.12	0.10	0.10	0.05
Stock-Based Compensation	2.35	1.80	2.54	2.48	1.63	1.81	1.01	1.09	1.33	1.26	1.01	0.50	0.39	0.65	0.77	0.60	0.65	14
Change in Accounts Payable	-2.78	3.02	-2.58	1.77	-2.55	2.92	-0.66	0.06	0.33	-0.17	0.04	-0.26	-0.10	0.54	1.67	-0.31	-0.92	1.02
Operating Cash Flow	-14	-1.11	-6.79	-11	-12	-6.45	-1.79	-7.93	-4.97	-10	-7.13	-7.94	-3.01	-5.19	-4.27	-3.84	-4.22	-2.53
Capital Expenditures	-0.03	-0.01	-0.05	-0.01	-0.01	-0.43	0.00	-0.01	-0.02	-0.01	0.00	-0.02	-0.01	-0.01	-0.04	-0.24	0.00	-0.48
Investing Cash Flow	-0.62	-3.86	-0.25	-0.16	-0.24	-0.76	-0.39	-0.28	-0.06	0.04	-0.19	0.02	-0.27	-0.03	-0.43	-0.15	-0.19	-0.51
Stock Issued	–	-0.27	0	0.27	0	83	–	–	–	–	–	–	–	–	–	–	–	–
Financing Cash Flow	-0.10	-0.10	-0.10	0.17	-0.10	78	2.32	-0.09	-0.02	-0.02	0.00	-0.01	0.03	–	–	–	104	-1.19
Foreign Exchange Rate Adjustments	-0.19	1.77	-0.13	-0.91	-5.39	-2.09	0.11	2.73	-2.84	1.53	1.23	-1.28	1.47	0.92	4.88	-3.48	-1.84	0.00
Free Cash Flow	-14	-1.12	-6.84	-11	-12	-6.89	-1.79	-7.94	-4.99	-10	-7.13	-7.96	-3.01	-5.20	-4.31	-4.08	-4.22	-3.01
Income Taxes Paid	0	-7.70	–	–	0	0	-5.16	0	0.00	-0.01	-0.01	0	-2.98	0.00	0.01	-2.66	-0.05	-0.01

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 4.73
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 404.0%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.